Haemonetics Corporation Stock News

SG Capital sold 731,892 shares of Haemonetics. The investment firm currently holds 175,000 shares.

It was something of an outlier in booking gains on a bearish day for stocks overall. This was the result of an investor-pleasing quarterly earnings report.

Haemonetics Corporation remains a Buy, supported by robust profit margins, strong cash flow, and leading TEG and plasma businesses driving organic growth. HAE reported improved gross and operating margins, raised full-year EPS guidance to $4.80–$5.00, and increased free cash flow outlook to $170–210 million. The company's valuation is attractive at a 14x forward P/E, below industry averages and...

The London Company Small Cap portfolio increased 1.9% gross (1.6% net) during the quarter vs. a 12.4% increase in the Russell 2000 Index. Armstrong World Industries' shares outperformed in the quarter due to beating expectations, driven by better-than-expected volumes, favorable positioning in key verticals, and strong operating leverage. Interparfums was a bottom holding as retailers are manag...

Haemonetics Corporation ( HAE ) Q2 2026 Earnings Call November 6, 2025 8:00 AM EST Company Participants Olga Guyette - Senior Director of Investor Relations Christopher Simon - CEO, President & Director James D'Arecca - CFO, Executive VP & Financial Officer Conference Call Participants Rohin Patel - JPMorgan Chase & Co, Research Division Marie Thibault - BTIG, LLC, Research Division David Resco...

Financial release and supplemental presentation accessible online BOSTON , Nov. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2026, which ended September 27, 2025, are available on the Company's Investor Relations website at www.haemonetics.com. The Company will host a conference call and webcast with investors an...

Supply has tightened over the past few years, setting NAND up for strong demand and pricing amid constrained supply. TSEM produces Silicon Photonics chips that are used in optical transceivers, which connect data center servers via optics rather than copper Ethernet. Everus Construction Group, Inc. (ECG), a commercial and utilities construction company, rounded out the list of top contributors.

BOSTON , Oct. 9, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, November 6, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on November 6, 2025.